Rafarma Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RAFA research report →
Price Chart
About the company
Rafarma Pharmaceuticals, Inc. is a diversified pharmaceutical enterprise that manufactures and distributes a range of medicinal products, including generic antibiotics and specialized drugs, within the Russian market. Its product portfolio encompasses anti-cancer medications, cephalosporin-derived compounds, and non-beta-lactam antibiotics.
- CEO
- Sergey Brusnitsin
- IPO
- 2012
- Employees
- 700
- HQ
- Sandy, UT, US
Get TickerSpark's AI analysis on RAFA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.13M
- P/E
- 13.70
- PEG
- 0.44
- P/S
- 0.34
- P/B
- 0.30
- EV/EBITDA
- 6.02
- Div Yield
- 0.00%
- Gross Margin
- 8.48%
- Op Margin
- 5.45%
- Net Margin
- 3.93%
- ROE
- 3.48%
- ROIC
- 3.94%
Latest fiscal year · YoY change
- Revenue
- $9.18M+1.1%
- Gross Profit
- $761.00K+12.9%
- Op Income
- $489.00K
- Net Income
- $349.00K+31.2%
- EPS
- $0.00+33.3%
- OCF Growth
- +154.5%
- FCF Growth
- -136.4%
- 52W High
- $0.10
- 52W Low
- $0.00
- 50D MA
- $0.03
- 200D MA
- $0.05
- Beta
- 0.64
- RSI (14)
- 56
- Avg Volume
- 9.86K
No earnings-call transcripts are available for RAFA yet.
- Free Float
- 0.0%
- Shares Outstanding
- 87.77M
- Float Shares
- 0
Our RAFA coverage
Recent articles, reports, and earnings notes.
No research on RAFA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RAFA report →Rafarma Pharmaceuticals to Present at the Virtual Life Science Investor Forum March 13th
globenewswire.com · Mar 12
Rafarma pharmaceutical updates: registration of Rafarma microspheres in South Korea
globenewswire.com · Jul 4
Rafarma pharmaceutical updates: creation of a joint research and production enterprise in Busan (South Korea) between Rafarma and the Korean pharmaceutical company Woods Medical Care
globenewswire.com · Jul 3
Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifesciences (Pvt) Ltd and El Salvador University
globenewswire.com · Dec 11
Rafarma Pharmaceutical news update
globenewswire.com · Nov 30
Rafarma Enters Negotiations With Leading Global Producer of Precious Metals to Localize Production of Platinum-Based Cancer Drugs
globenewswire.com · Aug 19
Letter to Shareholders from the Chairman of the Board Ilya Shpurov
globenewswire.com · Aug 10
Rafarma Signs Trilateral Investment Agreement Officially Launching Tashkent Pharmaceutical Plant Build
globenewswire.com · Jul 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.